[go: up one dir, main page]

CN113881992A - A new type of coated medical porous zinc material and preparation method thereof - Google Patents

A new type of coated medical porous zinc material and preparation method thereof Download PDF

Info

Publication number
CN113881992A
CN113881992A CN202111153818.3A CN202111153818A CN113881992A CN 113881992 A CN113881992 A CN 113881992A CN 202111153818 A CN202111153818 A CN 202111153818A CN 113881992 A CN113881992 A CN 113881992A
Authority
CN
China
Prior art keywords
sample
solution
zinc
preparing
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111153818.3A
Other languages
Chinese (zh)
Other versions
CN113881992B (en
Inventor
顾雪楠
王一凡
汤红艳
陈凯
樊瑜波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beihang University
Original Assignee
Beihang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beihang University filed Critical Beihang University
Priority to CN202111153818.3A priority Critical patent/CN113881992B/en
Publication of CN113881992A publication Critical patent/CN113881992A/en
Application granted granted Critical
Publication of CN113881992B publication Critical patent/CN113881992B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D5/00Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
    • C25D5/54Electroplating of non-metallic surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/047Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/306Other specific inorganic materials not covered by A61L27/303 - A61L27/32
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C26/00Coating not provided for in groups C23C2/00 - C23C24/00
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D21/00Processes for servicing or operating cells for electrolytic coating
    • C25D21/10Agitating of electrolytes; Moving of racks
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D21/00Processes for servicing or operating cells for electrolytic coating
    • C25D21/12Process control or regulation
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D3/00Electroplating: Baths therefor
    • C25D3/02Electroplating: Baths therefor from solutions
    • C25D3/22Electroplating: Baths therefor from solutions of zinc
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D5/00Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D5/00Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
    • C25D5/48After-treatment of electroplated surfaces
    • C25D5/50After-treatment of electroplated surfaces by heat-treatment
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D5/00Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
    • C25D5/60Electroplating characterised by the structure or texture of the layers
    • C25D5/623Porosity of the layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Electrochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Automation & Control Theory (AREA)
  • Dispersion Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Chemically Coating (AREA)

Abstract

本发明公开了一种新型涂层化医用多孔锌材料材料及其制备方法,其制备步骤主要包括:将多孔模板依次进行脱脂、粗化除膜及导电化处理,之后将其作为阴极,纯锌板作为阳极,接通直流电源,在硫酸锌盐电镀溶液中进行恒流电沉积,在模板表面均匀沉积一定厚度锌层后,将其放入真空电阻炉中烧结处理去除模板,将烧结处理得到的多孔锌在涂层反应溶液的水热釜中进行水热反应,在其表面负载一层均匀的涂层。本发明所制备的多孔锌孔径均匀且相互连通,孔隙率在95%以上,生物相容性良好,适用于骨缺损填充修复等组织工程支架领域,具有广阔的应用前景。

Figure 202111153818

The invention discloses a novel coated medical porous zinc material and a preparation method thereof. The preparation steps mainly include: degreasing, roughening and film removal and conducting treatment of a porous template in sequence, and then using it as a cathode, pure zinc The plate is used as the anode, the DC power supply is connected, and the constant current electrodeposition is carried out in the zinc sulfate electroplating solution. After a certain thickness of zinc layer is uniformly deposited on the surface of the template, it is placed in a vacuum resistance furnace for sintering treatment to remove the template, and the sintering treatment is used to obtain The porous zinc is hydrothermally reacted in the hydrothermal kettle of the coating reaction solution, and a uniform coating is supported on its surface. The porous zinc prepared by the invention has a uniform and interconnected pore size, has a porosity of more than 95%, and has good biocompatibility, is suitable for the field of tissue engineering scaffolds such as bone defect filling and repair, and has broad application prospects.

Figure 202111153818

Description

Novel coated medical porous zinc material and preparation method thereof
Technical Field
The invention relates to a novel coated medical porous zinc material and a preparation method thereof. The material has a structure similar to that of cancellous bone, the holes are communicated with each other, the porosity is high, capillary vessels can be formed in the material, various nutrients can be provided for bone regeneration, the material has good biocompatibility, the bone regeneration can be induced, and the material belongs to the technical field of biomedical metal material design and preparation.
Background
The porous metal material is also called foam metal, is a multifunctional material with excellent performance, is widely applied to the fields of automobiles, environmental protection, aerospace and the like, and also shows great application prospect in the field of biomedical implant materials. The traditional processed metal implant can generate stress shielding effect due to mismatching of elastic modulus and bone in vivo, so that the implant fails prematurely, and the biomedical porous metal can reduce the strength and elastic modulus of the material by controlling the aperture and porosity, and improve the biomechanical compatibility so that the biomedical porous metal is matched with bone tissues better. In addition, the pores of the open porous metal are communicated with each other to form a channel, which is beneficial to the transmission of body fluid and nutrient substances in the material and further promotes the regeneration and repair of bone tissues.
At present, people mainly focus on inert metals such as stainless steel, titanium alloy, tantalum, cobalt-chromium alloy and the like for research on medical porous metals. However, these non-biodegradable materials all cause chronic local inflammation and physiological irritation, and removal by secondary surgery is unavoidable. In recent years, there has been an increasing interest in the use of biodegradable metals in biomedicine. The inherent strength and ductility of the degradable metal can ensure that the degradable metal is applied to the repair of hard tissues such as bones, and the like, and the biodegradability can also ensure that patients can be prevented from suffering from secondary taking-out operations. The most widely studied degradable metals include magnesium, iron, zinc and their alloys, among which zinc exhibits a more favorable degradation rate than magnesium and iron, and its degradation products are completely bioabsorbable without releasing excessive hydrogen. And as a trace element necessary for a human body, zinc not only can promote osteogenesis and inhibit bone tissue loss and inflammation-related diseases, but also plays an important role in cartilage matrix metabolism (SOX9) and cartilage II gene expression, and the medical porous metal prepared by adopting pure zinc is expected to become a new-generation bone implant material.
The method for preparing the porous metal mainly comprises a sintering method, a powder metallurgy method, a seepage casting method and the like. The methods generally have the problems of poor pore connectivity, low porosity and the like, and are difficult to be used for preparing medical porous zinc with higher requirement on pore structure.
Furthermore, the biocompatibility of pure zinc depends on the concentration of zinc ions in vivo, i.e., low concentrations of zinc ions are beneficial to cells, while high concentrations of zinc ions are harmful to cells. The directly prepared pure zinc porous material can bring the risk of rapid release of zinc ions while the specific surface area is increased, and the loading of a coating with excellent biocompatibility on the surface is an effective method for solving the problem. An organic metal framework (MOFs) is a crystal material formed by self-assembling an organic ligand and metal ions through coordination bonds, has the advantages of high specific surface area, high porosity, easy functionalization and the like, and has wide application prospects in the field of biomedicine. Bioactive metal elements can be loaded on the surface of the porous zinc through the MOFs coating, so that the biocompatibility and the biological functionality of the material are improved. Magnesium is a necessary nutrient element for human bodies, has excellent biocompatibility and can promote the regeneration of bone tissues, and magnesium-based MOFs materials are also MOFs materials with mature preparation processes.
The porous zinc material which has the structure similar to that of bone tissue, the mutual communication of pores, high porosity and good biocompatibility and biological functionality is prepared at present, and has important significance for repairing and treating bone defects.
Disclosure of Invention
The invention aims to prepare a biomedical porous zinc material, the porous zinc in the invention has highly communicated three-dimensional through holes, high porosity and uniform structure, and meanwhile, the Cu-Mg-based coating is loaded on the surface of the porous zinc, so that the biocompatibility of the material is improved, the material has certain biological functionality, and the bone regeneration can be promoted.
The invention relates to a preparation method of a novel coated medical porous zinc material, which comprises the following steps:
step one, template pretreatment;
step 11, sample preparation;
cutting the polyurethane sponge into the size of required size (length multiplied by width, 50mm multiplied by 50mm) to form a first sample;
the pore diameter of the polyurethane sponge sample is 40PPI, 50PPI and 60 PPI.
Step 12, preparing chemical degreasing fluid;
20-40 g of NaOH and Na are needed in 1L of chemical degreasing solution220-30 g of CO and Na3PO45-10 g of OP emulsifier, 0.5-1.0 ml of OP emulsifier and the balance of deionized water.
The pH value of the degreasing fluid is kept between 10 and 12.
Step 13, degreasing the organic solvent;
immersing the first sample into absolute ethyl alcohol, repeatedly extruding and stirring for 10-60 s for organic solvent degreasing, taking out, and washing with distilled water for 5-10 minutes to obtain a second sample;
step 14, chemical degreasing treatment;
immersing the second sample into the chemical degreasing solution prepared in the step 12, repeatedly extruding and stirring for 5-10 minutes for chemical degreasing, taking out the second sample, and washing the second sample with distilled water for 5-10 minutes to obtain a third sample;
step two, coarsening and membrane removing treatment;
step 21, preparing a roughening solution;
KMnO required for preparing 1L of coarsening solution40.5 to 1.0g, H2SO40.03-0.06 ml and the balance of deionized water.
The pH value of the coarsening solution is kept between 2 and 3.
Step 22, preparing a membrane removing solution;
preparation of 1L of the desired C for the membrane removal solution2H2O4The oxalic acid is 5-10 g and the balance of deionized water.
Step 23, coarsening;
heating the coarsening solution to 45 ℃, then immersing the third sample into the heated coarsening solution, repeatedly extruding and stirring for 5-10 minutes for coarsening, taking out, and washing with distilled water for 5-10 minutes to obtain a fourth sample;
step 24, membrane removal treatment;
heating the film removing solution to 55 ℃, then immersing the fourth sample into the heated film removing solution, repeatedly extruding and stirring for 5-10 minutes to carry out hot film removal, taking out, washing with distilled water for 5-10 minutes, and airing to obtain a fifth sample;
conducting treatment;
fully and uniformly coating the graphite conductive adhesive on the fifth sample to obtain a sixth sample;
curing the sixth sample in a vacuum drying oven or naturally curing the sixth sample at room temperature to obtain a seventh sample;
the curing temperature in a vacuum drying oven is 60-90 ℃, and the curing time is 1-2 h;
the natural curing time at room temperature of 25 ℃ is 24 h.
Step four, preparing a zinc layer by electrodeposition;
step 41, preparing sulfate electrogalvanizing liquid;
preparing 1L of ZnSO required by sulfate electroplating solution4200 to 250g of Al2(SO4)315 to 20g of KAl (SO)4)235 to 45g of Na2SO420-30 g and the balance of deionized water.
The pH value of the sulfate electroplating solution is kept between 3 and 4;
step 42, performing electrodeposition by adopting a constant current method;
guiding the sulfate electrogalvanizing solution obtained in the step 41 into a deposition tank, placing the deposition tank on a constant-temperature water bath stirring device, and placing magnetons into an electrodeposition tank for stirring; setting the rotating speed of a magnetic stirrer to be 400-600 r/min, and the temperature of the plating solution to be 25-40 ℃;
taking the seventh sample as a cathode, and fixing two sides of the cathode by hollow copper sheets;
two 5mm pure zinc plates are used as double anodes and are placed on two sides of a cathode;
performing electrodeposition by adopting a constant current method, wherein the current density is 0.04-0.08A/mm2Depositing for 1-2 hours, adding additives in a deposition period according to the consumption rate of 0.3 mL/A.H, cleaning with distilled water after electrodeposition, and airing to prepare zinc with a porous structure, namely an eighth sample;
in the invention, the additive comprises a brightener and a softener, in particular to a CT-1 type brightener and a CT-1 type softener produced by limited chemical companies of Jiangsu Mengde electroplating chemicals.
In the invention, the current density is set to be 0.04-0.08A/mm2The apparent current density was obtained based on the apparent area of the seventh sample exposed to the plating solution.
Step five, sintering treatment;
the eighth sample is packaged in a vacuum mode by a quartz tube and is placed in a sintering furnace;
adjusting the sintering temperature to 300-350 ℃, the sintering temperature rise speed to 5-10 ℃/min, and the sintering time to 1-2 h; and cooling the sample to 25-40 ℃ along with the furnace after the sample is sintered, and taking out the sample to obtain a ninth sample.
Step six, coating loading;
step 61, preparing a reaction solution;
the concentration of the reaction solution is 1.5-3 mmol of solute added in each 70mL of solvent.
The solute is an organic ligand and a metal salt in a molar ratio of 3: 1. The organic ligand is preferably 2, 5-dihydroxyterephthalic acid (DHTA). The metal salt is magnesium nitrate or a combination of magnesium nitrate and copper nitrate.
The solvent is N, N-Dimethylformamide (DMF), water and ethanol in a volume ratio of 15:1: 1.
Step 62, carrying out hydrothermal reaction;
and vertically suspending the ninth sample in a polytetrafluoroethylene inner lining of a hydrothermal kettle, adding the reaction solution, putting the hydrothermal kettle into an oven for hydrothermal reaction, cooling to 25-40 ℃, and taking out to obtain a tenth sample.
The hydrothermal reaction temperature is 120-125 ℃, and the reaction time is 4-8 h.
Step 63, post-processing;
and (3) soaking the tenth sample in DMF for 10-30 min to remove unreacted solvent, and then washing with methanol to remove DMF to obtain an eleventh sample.
And (3) drying the eleventh sample in an oven at the temperature of 60-80 ℃ for 10-40 minutes, and taking out to obtain a twelfth sample.
Compared with the prior art, the coated biomedical porous zinc material has the following advantages:
firstly, most of the existing methods for preparing medical porous zinc are a seepage casting method and a powder metallurgy method, and CN 107354335A discloses a method and a device for preparing medical open-cell foam zinc materials, wherein the method comprises the steps of sintering a calcium chloride preform, placing metal zinc in a vacuum seepage device for temperature rise and pressure rise to carry out seepage casting, and removing preform particles by water dissolution, wherein the porosity of the porous zinc material obtained by the method is 59-70%; CN 110449584A discloses a method for preparing medical degradable open-cell foam zinc, which comprises the steps of mixing zinc powder and a pore-forming agent, carrying out pressure sintering in a mould, and removing the pore-forming agent through water dissolution, wherein the porosity of the open-cell foam zinc obtained by the method is 40-78%, and the pore diameter is 0.8-2 mm. The two disclosed preparation methods of the porous zinc have the advantages of low porosity, large pore diameter, difficulty in control, incapability of ensuring uniform distribution and connectivity of internal pores, and existence of partially closed pores. The invention adopts an electrodeposition method and takes polyurethane as a template, the prepared porous zinc has uniform pore size distribution and high porosity, and the problems of low porosity and non-uniform pore size in the prior art are solved. In addition, the pore diameter and porosity of the porous zinc can be adjusted by replacing different polyurethane sponge matrixes.
Secondly, the invention adopts nontoxic and environment-friendly zinc sulfate salt as the main component of the electroplating solution, and can obtain an open porous zinc structure with uniform plating layer, smooth and complete surface by controlling the current density and the deposition time and adjusting the proportion of the electroplating solution.
The porous zinc prepared by the invention has highly communicated open pores, has a structure similar to that of cancellous bone, is favorable for forming a capillary network in the porous zinc, promotes the transportation of body fluid and nutrient substances, and reduces the risk of necrosis of the central part of the bone defect due to ischemia.
The Mg-based MOFs coating loaded on the surface of the porous zinc prepared by the invention can improve the biocompatibility of the material and promote the bone regeneration of the defect part, and bioactive metal elements such as copper ions with antibacterial and vascularization promoting effects are added on the basis, so that the material has multiple biological functions.
Therefore, compared with the prior art, the invention can prepare the medical open-pore porous zinc material with high porosity and high connectivity, has good biocompatibility and has wide application prospect in the field of tissue engineering scaffolds for bone defect filling repair and the like.
Drawings
Fig. 1 is a scanning electron microscope image of the porous zinc material prepared to the end of step five in example 1 of the present invention, in which it can be observed that the material is in a three-dimensional network structure, the internal pores are uniform and connected, the average diameter of the pores is 0.51mm, and the porosity is 97%.
FIG. 2 is a scanning electron microscope image of the coated porous zinc material prepared in example 1 of the present invention, wherein the porous zinc surface is covered with a dense Cu-Mg-based coating.
FIG. 3 is an interface scanning electron microscope image of the coating of the coated porous zinc prepared in example 1 of the present invention, wherein the coating structure is a closely packed spherical structure, and the average thickness of the coating is 30 μm.
Fig. 3A is a scanning electron microscope image of a test point of the coating interface of the coated porous zinc prepared in example 1 of the present invention.
FIG. 4 is an XRD diffraction pattern of the coated porous zinc surface coating prepared in example 1 of the present invention, the material surface coating is consistent with the characteristic peak-to-peak value of standard Mg-MOF-74, indicating that the sample surface coating composition is mainly Mg-MOF-74.
FIG. 5 shows the cytotoxicity test results of the coated porous zinc in example 1 of the present invention on MC3T3-E1, and the cytotoxicity of the test sample is significantly reduced and the biocompatibility is improved compared with that of the pure zinc material.
Detailed Description
The present invention will be described in further detail with reference to the accompanying drawings and examples.
Example 1
Step one, template pretreatment;
step 11, sample preparation;
cutting 50PPI polyurethane sponge into a length of 50mm and a width of 50mm to obtain a first sample;
step 12, preparing chemical degreasing fluid;
35g of NaOH and Na are needed in 1L of chemical degreasing solution2CO is 25g and Na3PO410g of OP emulsifier, 0.5ml of OP emulsifier and the balance of deionized water.
The pH value of the degreasing fluid is kept between 10 and 12.
Step 13, degreasing the organic solvent;
immersing the first sample into absolute ethyl alcohol, repeatedly extruding and stirring for 60s for organic solvent degreasing, taking out, and washing with distilled water for 5 minutes to obtain a second sample;
step 14, chemical degreasing treatment;
immersing the second sample into the chemical degreasing solution prepared in the step 12, repeatedly extruding and stirring for 5 minutes for chemical degreasing, taking out the second sample, and washing the second sample with distilled water for 5 minutes to obtain a third sample;
step two, coarsening and membrane removing treatment;
step 21, preparing a roughening solution;
KMnO required for preparing 1L of coarsening solution4Is 1g, H2SO40.05ml and the balance deionized water.
The pH value of the coarsening solution is kept between 2 and 3.
Step 22, preparing a membrane removing solution;
preparation of 1L of the desired C for the membrane removal solution2H2O4Oxalic acid 10g and the balance deionized water.
Step 23, coarsening;
heating the coarsening solution to 45 ℃, then immersing the third sample into the heated coarsening solution, repeatedly extruding and stirring for 5 minutes for coarsening, taking out, and washing with distilled water for 5 minutes to obtain a fourth sample;
step 24, membrane removal treatment;
heating the membrane removing solution to 55 ℃, then immersing the fourth sample into the heated membrane removing solution, repeatedly extruding and stirring for 5 minutes to carry out hot membrane removal, taking out, washing with distilled water for 5 minutes, and then airing to obtain a fifth sample;
conducting treatment;
fully and uniformly coating the graphite conductive adhesive on the fifth sample to obtain a sixth sample;
curing the sixth sample in a vacuum drying oven to obtain a seventh sample;
the curing temperature in the vacuum drying oven is 60 ℃, and the curing time is 1 h;
step four, preparing a zinc layer by electrodeposition;
step 41, preparing sulfate electrogalvanizing liquid;
preparing 1L of ZnSO required by sulfate electroplating solution4250g of Al2(SO4)3Is 20g, KAl (SO)4)245g of Na2SO430g and balance deionized water.
The pH value of the sulfate electroplating solution is kept between 3 and 4;
step 42, performing electrodeposition by adopting a constant current method;
guiding the sulfate electrogalvanizing solution obtained in the step 41 into a deposition tank, placing the deposition tank on a constant-temperature water bath stirring device, and placing magnetons into an electrodeposition tank for stirring; setting the rotation speed of a magnetic stirrer at 600r/min, the temperature of the plating solution at 35 ℃ and the current density at 0.040A/cm2The deposition time is 1.5 h;
taking the seventh sample as a cathode, fixing two sides of the seventh sample by hollow copper sheets, wherein the exposed area of each side of each copper sheet is 16cm2
Two pure zinc plates with the diameter of 5mm are used as double anodes and are placed on two sides of a cathode, and the cross section of each zinc plate is a square thin plate with the diameter of 50mm multiplied by 50 mm;
in the present invention, electrodeposition was carried out by a constant current method with a set current density of 0.040A/mm2The zinc plating additive (1mL/L brightener and 15mL/L softener) is added in portions according to the consumption rate of 0.3 mL/A.H during the deposition, and after the electrodeposition, the zinc plating additive is washed by distilled water and dried to prepare porous zinc, namely an eighth sample.
CT-1 type brightener and CT-1 type softening agent produced by Jiangsu Mengde electroplating chemical company Limited are selected.
In the present invention, the current density was set to 0.04A/cm2The apparent current density was obtained based on the apparent area of the seventh sample exposed to the plating solution.
Step five, sintering treatment;
the eighth sample is packaged in a vacuum mode by a quartz tube and is placed in a sintering furnace;
and adjusting the sintering temperature to 300 ℃, the sintering temperature rise speed to 5 ℃/min, the sintering time to 1.5h, cooling to 30 ℃ in the furnace along with the furnace after sintering, and taking out to obtain a ninth sample.
Referring to fig. 1, an environmental scanning electron microscope is used to perform morphology analysis on the ninth sample, and it can be observed that the ninth sample has three-dimensionally connected pore channels, and the interior of the skeleton is a hollow structure.
Step six, coating loading;
step 61, preparing a reaction solution;
the concentration of the reaction solution was 3mmol of solute per 70mL of the solvent.
The solutes were 639mg of magnesium nitrate hexahydrate, 1mg of copper nitrate hexahydrate and 160mg of DHTA (2, 5-dihydroxyterephthalic acid).
The solvent was 60mL of DMF to which were added 4mL of deionized water and 4mL of absolute ethanol, respectively.
Step 62, carrying out hydrothermal reaction;
and vertically suspending the ninth sample in a polytetrafluoroethylene inner lining of a hydrothermal kettle, adding the reaction solution, putting the hydrothermal kettle into an oven for hydrothermal reaction, cooling to 30 ℃, and taking out to obtain a tenth sample.
The hydrothermal reaction temperature is 120 ℃, and the reaction time is 4 h.
Step 63, post-processing;
the tenth sample was immersed in DMF for 10min to remove unreacted solvent, and then washed with methanol to remove DMF, to obtain an eleventh sample.
The eleventh sample was dried in an oven at 60 ℃ for 20 minutes and then taken out to obtain a twelfth sample.
Referring to fig. 2, an environmental scanning electron microscope is used to perform morphology analysis on the twelfth sample, and it can be observed that the twelfth sample has three-dimensionally connected pore channels, the interior of the porous skeleton is of a hollow structure, the porosity is more than 95%, the average pore diameter is 0.51mm, and the distribution is uniform.
Referring to fig. 3 and 3A, the twelfth sample was analyzed for morphology using an environmental scanning electron microscope, and it was observed that the surface of the porous skeleton was coated with a layer of coating having an average thickness of 30 μm.
Referring to fig. 4 (diffraction angle on abscissa and relative intensity on ordinate), the twelfth sample was subjected to composition analysis, the surface coating of the sample was scraped off, and the phase analysis of the coating powder was performed using an X-ray diffractometer under the following test conditions: cu Ka radiation; x-ray generator power: 2.2kW, a scanning range of 5-50 degrees and a scanning speed of 5 degrees/min. The XRD pattern shows that the characteristic peak of the twelfth sample is consistent with the peak value of the characteristic peak in the standard XRD pattern of Mg-MOF-74, which indicates that the surface coating component of the twelfth sample is mainly Mg-MOF-74.
Soaking surface area 2cm with 5mL of serum free Hepes free alpha-MEM medium2The sample is prepared into leaching liquor, and after leaching is carried out for 72 hours in an incubator at 37 ℃, the leaching liquor is taken out and stored in a 15mL centrifuge tube in a super clean bench. Cytotoxicity assay was carried out using Cell Counting Kit-8 Kit, wherein MC3T3-E1 cells with good growth status were seeded in 96-well plate at a density of 100. mu.L per 3000 cells per well, and CO was incubated at 37 ℃ in a 96-well plate2Culturing in incubator for 1 day to allow cell to adhere to wall, sucking out old culture medium, adding 100 μ L of α -MEM complete culture medium with volume ratio of 50%, 25%, 10% to positive control group, adding 100 μ L of α -MEM to negative control group, culturing for 2 days, taking out old culture medium, adding 100 μ L of α -MEM culture medium containing 10% CCK8 per well, culturing at 37 deg.C in CO at 37 deg.C2And (5) incubating in an incubator for 1h, measuring the absorbance value of each hole under 450nm by using a microplate reader, and calculating the cell activity. Referring to fig. 5 (the abscissa is different coating materials, and the ordinate is cell viability), cytotoxicity analysis is performed on the twelfth sample, and it can be seen that compared with the pure zinc material, the twelfth sample has improved cell viability under the condition of culturing with different concentrations of leaching liquor, and has improved cell viability to more than 80% under the condition of culturing with 25% of leaching liquor, so that cytotoxicity is obviously reduced, and biocompatibility is improved.
The main instruments required for the analysis of the sample properties are shown in table 1:
TABLE 1 Main instruments used in the experiment
Figure BDA0003288028630000101
The main reagents required for the performance analysis of the samples are shown in table 2:
TABLE 2 Main reagents used in the experiment
Experimental reagent Production company
MEM Alpha Medium American Saimer Feishale Gibco
0.25% Trypsin American Saimer Feishale Gibco
Fetal bovine serum American Saimer Feishale Gibco
Cell counting kit-8 kit Dojindo chemical research of Japan
Phosphate Buffer Solution (PBS) BEIJING SOLARBIO TECHNOLOGY Co.,Ltd.
Example 2
Example 2 differs from example 1 in that:
step one, template pretreatment;
the pore diameter of the polyurethane sponge selected in the step 11 is 40 PPI;
step four, preparing a zinc layer by electrodeposition;
the temperature of the plating solution in the step 42 is 30 ℃, and the deposition time is 1 h;
step five, sintering treatment;
and 5, setting the sintering time in the fifth step to be 1 h.
Step six, coating loading;
step 61, preparing a reaction solution;
the concentration of the reaction solution was 3mmol of solute per 70mL of the solvent.
The solutes were 640mg of magnesium nitrate hexahydrate and 160mg of DHTA.
The solvent was 60mL of DMF to which were added 4mL of deionized water and 4mL of absolute ethanol, respectively.
Step 62, carrying out hydrothermal reaction;
and vertically suspending the ninth sample in a polytetrafluoroethylene inner lining of a hydrothermal kettle, adding the reaction solution, putting the hydrothermal kettle into an oven for hydrothermal reaction, cooling to 40 ℃, and taking out to obtain a tenth sample.
The hydrothermal reaction temperature is 125 ℃, and the reaction time is 6 h.
Performance analysis
The porous zinc material prepared by the method of the embodiment 2 has three-dimensionally communicated pore channels, the interior of the porous framework is of a hollow structure, the porosity is more than 95%, the average pore diameter is 0.64mm, the porous framework is uniformly distributed, and the surface of the porous framework is wrapped by a coating layer with the average thickness of 30 microns.
Example 3
Example 3 differs from example 1 in that:
step one, template pretreatment;
the pore diameter of the polyurethane sponge selected in the step 11 is 60 PPI;
step four, preparing a zinc layer by electrodeposition;
the temperature of the plating solution in the step 42 is controlled to be 40 ℃, and the deposition time is 1 h;
step five, sintering treatment;
and (5) keeping the sintering heat preservation time in the fifth step for 2 hours.
Step six, coating loading;
step 61, preparing a reaction solution;
the concentration of the reaction solution was 3mmol of solute per 70mL of the solvent.
The solute was 638mg magnesium nitrate hexahydrate, 2mg copper nitrate hexahydrate and 160mg DHTA.
The solvent was 60mL of DMF to which were added 4mL of deionized water and 4mL of absolute ethanol, respectively.
Performance analysis
The porous zinc material prepared by the method in the embodiment 3 has three-dimensionally communicated pore channels, the interior of the porous framework is of a hollow structure, the porosity is more than 95%, the average pore diameter is 0.42mm, the porous framework is uniformly distributed, and the surface of the porous framework is wrapped by a coating with the average thickness of 20 microns.
Example 4
Example 4 differs from example 1 in that:
step one, template pretreatment;
the pore diameter of the polyurethane sponge selected in the step 11 is 60 PPI;
step four, preparing a zinc layer by electrodeposition;
the temperature of the plating solution in the step 42 is 25 ℃, and the constant current density during deposition is 0.06A/cm2,;
Step five, sintering treatment;
and (5) keeping the sintering heat preservation time in the fifth step for 2 hours.
Step six, coating loading;
step 61, preparing a reaction solution;
the concentration of the reaction solution was 3mmol of solute per 70mL of the solvent.
The solutes were 637mg of magnesium nitrate hexahydrate, 3mg of copper nitrate hexahydrate and 160mg of DHTA.
The solvent was 60mL of DMF to which were added 4mL of deionized water and 4mL of absolute ethanol, respectively.
Performance analysis
The surface of the porous zinc material framework prepared in the embodiment 4 is wrapped by a layer of coating with the average thickness of 20 micrometers, the whole framework still has three-dimensional communicated pore channels, the interior of the porous framework is of a hollow structure, the porosity is more than 95%, the average pore diameter is 0.42mm, and the porous framework is uniformly distributed.

Claims (4)

1.一种新型涂层化医用多孔锌材料的制备方法,其特征在于包括有下列步骤:1. a preparation method of novel coating medical porous zinc material is characterized in that comprising the following steps: 步骤一,模板预处理;Step 1, template preprocessing; 步骤11,试样准备;Step 11, sample preparation; 将聚氨酯海绵裁成所需尺寸,成为第一试样;Cut the polyurethane sponge to the required size to become the first sample; 所述的聚氨酯海绵试样孔径为40PPI、50PPI、或者60PPI;The pore size of the polyurethane sponge sample is 40PPI, 50PPI, or 60PPI; 步骤12,配制化学脱脂液;Step 12, prepare chemical degreasing solution; 配制1L的化学脱脂液中所需NaOH为20~40g、Na2CO为20~30g、Na3PO4为5~10g、OP乳化剂为0.5~1.0ml和余量的去离子水;In preparing 1L of chemical degreasing solution, the required NaOH is 20-40g, Na 2 CO is 20-30g, Na 3 PO 4 is 5-10g, OP emulsifier is 0.5-1.0ml and the balance is deionized water; 脱脂液pH值保持在10~12之间;The pH value of the degreasing solution is kept between 10 and 12; 步骤13,有机溶剂的脱脂处理;Step 13, degreasing treatment of organic solvent; 将第一试样浸入无水乙醇中反复挤压搅拌10~60s进行有机溶剂脱脂,取出后用蒸馏水冲洗5~10分钟,得到第二试样;Immerse the first sample in anhydrous ethanol and repeatedly squeeze and stir for 10-60 s to degrease the organic solvent. After taking out, rinse with distilled water for 5-10 minutes to obtain the second sample; 步骤14,化学脱脂处理;Step 14, chemical degreasing treatment; 将第二试样浸入步骤12制得的化学脱脂液中,反复挤压搅拌5~10分钟进行化学脱脂,取出后用蒸馏水冲洗5~10分钟,得到第三试样;Immerse the second sample in the chemical degreasing solution obtained in step 12, repeatedly squeeze and stir for 5-10 minutes to carry out chemical degreasing, take out and rinse with distilled water for 5-10 minutes to obtain a third sample; 步骤二,粗化-除膜处理;Step 2, roughening-film removal treatment; 步骤21,配制粗化液;Step 21, preparing a coarsening solution; 配制1L的粗化溶液所需KMnO4为0.5~1.0g、H2SO4为0.03~0.06ml和余量的去离子水;The KMnO 4 required to prepare 1L of the coarsening solution is 0.5-1.0 g, the H 2 SO 4 is 0.03-0.06 ml and the balance of deionized water; 粗化溶液pH值保持在2~3之间;The pH value of the coarsening solution is kept between 2 and 3; 步骤22,配制除膜液;Step 22, preparing a film removal solution; 配制1L的除膜溶液所需草酸为5~10g和余量的去离子水;The oxalic acid required to prepare 1L of film removal solution is 5-10g and the balance of deionized water; 步骤23,粗化处理;Step 23, coarsening; 将粗化溶液加热至45℃,然后将第三试样浸入加热后的粗化溶液中,反复挤压搅拌5~10分钟进行粗化,取出后用蒸馏水冲洗5~10分钟,得到第四试样;The roughening solution is heated to 45°C, and then the third sample is immersed in the heated roughening solution, and the fourth sample is obtained by repeatedly pressing and stirring for 5-10 minutes for roughening, and then washing with distilled water for 5-10 minutes after taking it out. Sample; 步骤24,除膜处理;Step 24, film removal treatment; 将除膜溶液加热至55℃,然后将第四试样浸入加热后的除膜溶液中,反复挤压搅拌5~10分钟进行热除膜,取出后用蒸馏水冲洗5~10分钟,再晾干,得到第五试样;Heat the film removal solution to 55°C, then immerse the fourth sample in the heated film removal solution, repeatedly squeeze and stir for 5 to 10 minutes for thermal film removal, take out and rinse with distilled water for 5 to 10 minutes, and then air dry , the fifth sample is obtained; 步骤三,导电化处理;Step 3, conductive treatment; 将石墨导电胶充分涂匀在第五试样上,得到第六试样;Fully spread the graphite conductive adhesive on the fifth sample to obtain the sixth sample; 将第六试样在真空干燥箱中固化或在室温下自然固化,得到第七试样;The sixth sample is cured in a vacuum drying oven or naturally cured at room temperature to obtain the seventh sample; 在真空干燥箱中的固化温度为60℃~90℃,固化时间为1~2h;The curing temperature in the vacuum drying oven is 60℃~90℃, and the curing time is 1~2h; 在室温25℃下自然固化时间为24h;The natural curing time is 24h at room temperature of 25℃; 步骤四,电沉积制锌层;Step 4, electrodepositing the zinc layer; 步骤41,配制硫酸盐电镀锌液;Step 41, preparing sulfate electro-galvanizing solution; 配制1L的硫酸盐电镀液所需ZnSO4为200~250g、Al2(SO4)3为15~20g、KAl(SO4)2为35~45g、Na2SO4为20~30g和余量的去离子水;The required ZnSO 4 for preparing 1 L of sulfate electroplating solution is 200-250 g, Al 2 (SO 4 ) 3 is 15-20 g, KAl(SO 4 ) 2 is 35-45 g, Na 2 SO 4 is 20-30 g and the balance of deionized water; 硫酸盐电镀液pH值保持在3~4之间;The pH value of the sulfate electroplating solution is kept between 3 and 4; 步骤42,采用恒流法进行电沉积;Step 42, using a constant current method for electrodeposition; 将步骤41得到的硫酸盐电镀锌液导入沉积槽中,将沉积槽放在恒温水浴搅拌装置上,磁子放入电沉积槽中进行搅拌;设置磁力搅拌器转速为400~600r/min,镀液温度为25℃~40℃;The sulfate electro-galvanizing solution obtained in step 41 is introduced into the deposition tank, the deposition tank is placed on the constant temperature water bath stirring device, and the magnetron is placed in the electrodeposition tank for stirring; The liquid temperature is 25℃~40℃; 以第七试样作为阴极,两面用镂空的铜片固定;The seventh sample is used as the cathode, and the two sides are fixed with hollow copper sheets; 以两块5mm纯锌板作为双阳极,并放置于阴极两侧;Two 5mm pure zinc plates are used as double anodes and placed on both sides of the cathode; 采用恒流法进行电沉积,电流密度为0.04~0.08A/mm2,沉积时间为1~2小时,沉积期间参照0.3mL/A·H的消耗速率分次加入添加剂,电沉积后用蒸馏水清洗并晾干,制得多孔结构的锌,即第八试样;Electrodeposition was carried out by constant current method, the current density was 0.04-0.08A/mm 2 , and the deposition time was 1-2 hours. During the deposition, the additive was added in stages with reference to the consumption rate of 0.3mL/A·H, and washed with distilled water after electrodeposition. And air-dry to obtain zinc with porous structure, namely the eighth sample; 步骤五,烧结处理;Step 5, sintering treatment; 将第八试样用石英管真空封装,并置于烧结炉中;The eighth sample is vacuum-sealed with a quartz tube and placed in a sintering furnace; 调节烧结温度为300℃~350℃、烧结升温速度为5~10℃/min,烧结时间1~2h;试样烧结完成后随炉冷却至25℃~40℃再取出,得到第九试样;Adjust the sintering temperature to be 300°C to 350°C, the sintering heating rate to be 5 to 10°C/min, and the sintering time to be 1 to 2 hours; after the sample is sintered, it is cooled to 25°C to 40°C in the furnace and then taken out to obtain the ninth sample; 步骤六,涂层负载;Step 6, coating load; 步骤61,配制反应溶液;Step 61, preparing a reaction solution; 反应溶液浓度为每70mL溶剂里加入1.5~3mmol溶质;The concentration of the reaction solution is to add 1.5-3 mmol of solute per 70 mL of solvent; 所述溶质是摩尔比为3:1的有机配体和金属盐;所述有机配体优先为2,5-二羟基对苯二甲酸;所述金属盐为硝酸镁或者硝酸镁和硝酸铜;The solute is an organic ligand and a metal salt with a molar ratio of 3:1; the organic ligand is preferably 2,5-dihydroxyterephthalic acid; the metal salt is magnesium nitrate or magnesium nitrate and copper nitrate; 所述溶剂是体积比为15:1:1的N,N-二甲基甲酰胺、水、乙醇;The solvent is N,N-dimethylformamide, water, ethanol with a volume ratio of 15:1:1; 步骤62,水热反应;Step 62, hydrothermal reaction; 将第九试样垂直悬挂于水热釜的聚四氟乙烯内衬里,加入反应溶液,将水热釜放入烘箱进行水热反应,冷却至25℃~40℃后取出,得到第十试样;Hang the ninth sample vertically on the polytetrafluoroethylene lining of the hydrothermal kettle, add the reaction solution, put the hydrothermal kettle into an oven for hydrothermal reaction, cool it to 25°C to 40°C and take it out to obtain the tenth sample. Sample; 水热反应温度为120℃~125℃,反应时间为4~8h;The hydrothermal reaction temperature is 120℃~125℃, and the reaction time is 4~8h; 步骤63,后处理;Step 63, post-processing; 将第十试样在DMF中浸泡10~30min进行除去未反应的溶剂,再用甲醇清洗除去DMF,得到第十一试样;Soak the tenth sample in DMF for 10-30min to remove unreacted solvent, and then wash with methanol to remove DMF to obtain the eleventh sample; 将第十一试样放入温度为60℃~80℃的烘箱中干燥10~40分钟后,取出得到第十二试样。The eleventh sample was put into an oven with a temperature of 60°C to 80°C and dried for 10 to 40 minutes, and then taken out to obtain a twelfth sample. 2.根据权利要求1所述的新型涂层化医用多孔锌材料的制备方法,其特征在于:制得的医用多孔锌涂层的成分为Mg-MOF-74。2 . The method for preparing a novel coated medical porous zinc material according to claim 1 , wherein the composition of the prepared medical porous zinc coating is Mg-MOF-74. 3 . 3.根据权利要求1所述的新型涂层化医用多孔锌材料的制备方法,其特征在于:制得的医用多孔锌涂层的厚度为20~30微米。3 . The method for preparing a novel coated medical porous zinc material according to claim 1 , wherein the thickness of the prepared medical porous zinc coating is 20-30 microns. 4 . 4.根据权利要求1所述的新型涂层化医用多孔锌材料的制备方法,其特征在于:制得的医用多孔锌涂层在25%浸提液培养下细胞存活率提高至80%。4 . The method for preparing a novel coated medical porous zinc material according to claim 1 , wherein the prepared medical porous zinc coating has a cell survival rate of 80% under 25% leaching solution culture. 5 .
CN202111153818.3A 2021-09-29 2021-09-29 A novel coated medical porous zinc material and its preparation method Active CN113881992B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111153818.3A CN113881992B (en) 2021-09-29 2021-09-29 A novel coated medical porous zinc material and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111153818.3A CN113881992B (en) 2021-09-29 2021-09-29 A novel coated medical porous zinc material and its preparation method

Publications (2)

Publication Number Publication Date
CN113881992A true CN113881992A (en) 2022-01-04
CN113881992B CN113881992B (en) 2023-06-02

Family

ID=79008399

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111153818.3A Active CN113881992B (en) 2021-09-29 2021-09-29 A novel coated medical porous zinc material and its preparation method

Country Status (1)

Country Link
CN (1) CN113881992B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115920124A (en) * 2022-11-24 2023-04-07 中国科学院上海硅酸盐研究所 Functionalized biological ceramic composite scaffold material for osteochondral repair and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470072A (en) * 1967-03-13 1969-09-30 Pressed Steel Fisher Ltd Process for the electro-deposition of paint coating onto article having predeposited porous zinc layer
CN105624753A (en) * 2015-12-24 2016-06-01 广州中国科学院先进技术研究所 Technology for uniform deposition of HA (hydroxyapatite) coatings on medical porous titanium and titanium alloy
CN109811396A (en) * 2019-01-24 2019-05-28 北京航空航天大学 A kind of porous zinc and its preparation and application
CN110029383A (en) * 2019-03-15 2019-07-19 浙江工贸职业技术学院 A kind of degradable zinc-copper foam biological material
CN113215627A (en) * 2021-05-10 2021-08-06 中国石油大学(华东) Method for preparing super-hydrophobic zinc sulfide coating on surface of stainless steel

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470072A (en) * 1967-03-13 1969-09-30 Pressed Steel Fisher Ltd Process for the electro-deposition of paint coating onto article having predeposited porous zinc layer
CN105624753A (en) * 2015-12-24 2016-06-01 广州中国科学院先进技术研究所 Technology for uniform deposition of HA (hydroxyapatite) coatings on medical porous titanium and titanium alloy
CN109811396A (en) * 2019-01-24 2019-05-28 北京航空航天大学 A kind of porous zinc and its preparation and application
CN110029383A (en) * 2019-03-15 2019-07-19 浙江工贸职业技术学院 A kind of degradable zinc-copper foam biological material
CN113215627A (en) * 2021-05-10 2021-08-06 中国石油大学(华东) Method for preparing super-hydrophobic zinc sulfide coating on surface of stainless steel

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115920124A (en) * 2022-11-24 2023-04-07 中国科学院上海硅酸盐研究所 Functionalized biological ceramic composite scaffold material for osteochondral repair and preparation method thereof
CN115920124B (en) * 2022-11-24 2024-03-12 中国科学院上海硅酸盐研究所 Functional biological ceramic composite scaffold material for repairing bone cartilage and preparation method thereof

Also Published As

Publication number Publication date
CN113881992B (en) 2023-06-02

Similar Documents

Publication Publication Date Title
CN102268711B (en) Method for preparing biological composite coating on surface of magnesium-based material
Li et al. Corrosion resistance of in-situ growth of nano-sized Mg (OH) 2 on micro-arc oxidized magnesium alloy AZ31—Influence of EDTA
ZHANG Influence of solution temperature on corrosion resistance of Zn-Ca phosphate conversion coating on biomedical Mg-Li-Ca alloys
Zhao et al. Preparation and properties of composite MAO/ECD coatings on magnesium alloy
Liu et al. Photo-controlled degradation of PLGA/Ti3C2 hybrid coating on Mg-Sr alloy using near infrared light
He et al. A study of degradation behaviour and biocompatibility of Zn—Fe alloy prepared by electrodeposition
He et al. A novel porous Fe/Fe-W alloy scaffold with a double-layer structured skeleton: preparation, in vitro degradability and biocompatibility
CN103463685B (en) Preparation method of degradable porous structural tissue engineering bracket with high strength
CN103372232A (en) Micro-arc oxidation self-sealing hole active coating of magnesium-based implant material and preparation method of micro-arc oxidation self-sealing hole active coating
CN105274603A (en) Compound modified coating of magnesium or magnesium alloy surface carbon-containing nano tube and preparation method of compound modified coating
CN110029383B (en) Degradable zinc-copper foam biological material
He et al. Influence of EDTA-2Na on the hydroxyapatite coating deposited by hydrothermal-electrochemical method on Ti6Al4V surface
CN106987863A (en) The preparation technology of the bimodal nano-crystal nickel cobalt alloy of single pulse electrodpositing light two-phase
CN113881992A (en) A new type of coated medical porous zinc material and preparation method thereof
CN102560590B (en) Anode in-situ electrochemical method for preparing hydroxyapatite coating
CN104746073A (en) Magnesium alloy surface modification method
CN102899702B (en) Magnesium alloy surface composite treatment method
CN104922727B (en) A kind of bioactivity, porous titanium medical embedded material and preparation method thereof
Liu et al. Preparation and in vitro degradation behavior of biodegradable porous Zn-Li-Ca alloy bone repair scaffolds
CN114381778A (en) Method for preparing tantalum biological coating on surface of magnesium and magnesium alloy
CN105200413B (en) A kind of preparation method of calcium-phosphorus-tin composite coating on the surface of magnesium alloy
CN117626665A (en) A bioactive carbon fiber material and its preparation method, composite material and application
CN111910237A (en) Plasma bionic material micro-arc oxidation method and device
CN112899752A (en) Method for preparing MAO-LDH coating with corrosion resistance and antibacterial property on surface of medical magnesium alloy and application
Adhilakshmi et al. Cathodic electrodeposition of zinc–zinc phosphate–calcium phosphate composite coatings on pure iron for biodegradable implant applications

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant